Gilead Sciences to Release Third Quarter 2024 Financial Results on Wednesday, November 6, 2024
Gilead Sciences (Nasdaq: GILD) has announced that it will release its third quarter 2024 financial results on Wednesday, November 6, 2024, after the market closes. The company's management will host a webcast at 4:30 p.m. Eastern Time to discuss the results and provide a business update.
A live webcast will be available on the Investor Relations section of www.gilead.com and will be archived there for one year. Gilead Sciences is a biopharmaceutical company known for its breakthroughs in medicine, focusing on innovative treatments for life-threatening diseases such as HIV, viral hepatitis, COVID-19, and cancer. The company operates in more than 35 countries worldwide, with headquarters in Foster City, California.
Gilead Sciences (Nasdaq: GILD) ha annunciato che rilascerà i suoi risultati finanziari per il terzo trimestre del 2024 mercoledì 6 novembre 2024, dopo la chiusura del mercato. La direzione dell'azienda ospiterà un webcast alle 16:30, ora orientale, per discutere i risultati e fornire un aggiornamento aziendale.
Un webcast in diretta sarà disponibile nella sezione Relazioni con gli Investitori di www.gilead.com e sarà archiviato lì per un anno. Gilead Sciences è un'azienda biofarmaceutica nota per le sue scoperte in medicina, concentrandosi su trattamenti innovativi per malattie potenzialmente letali come HIV, epatite virale, COVID-19 e cancro. L'azienda opera in più di 35 paesi nel mondo, con sede a Foster City, California.
Gilead Sciences (Nasdaq: GILD) ha anunciado que liberará sus resultados financieros del tercer trimestre de 2024 el miércoles 6 de noviembre de 2024, después del cierre del mercado. La dirección de la empresa llevará a cabo un webcast a las 4:30 p.m., hora del Este, para discutir los resultados y proporcionar una actualización sobre el negocio.
Se podrá acceder a una transmisión en vivo en la sección de Relaciones con Inversores de www.gilead.com, la cual estará archivada durante un año. Gilead Sciences es una empresa biofarmacéutica conocida por sus avances en medicina, enfocándose en tratamientos innovadores para enfermedades potencialmente mortales como el VIH, hepatitis viral, COVID-19 y cáncer. La empresa opera en más de 35 países en todo el mundo, con sede en Foster City, California.
길리어드 사이언스 (Nasdaq: GILD)는 2024년 3분기 재무 결과를 2024년 11월 6일 수요일에 시장 종료 후 발표할 것이라고 발표했습니다. 회사 경영진은 동부 표준시 오후 4:30에 결과를 논의하고 사업 업데이트를 제공하기 위해 웨비나를 개최할 예정입니다.
실시간 웨비나는 www.gilead.com의 투자자 관계 섹션에서 제공되며, 1년 동안 아카이브될 것입니다. 길리어드 사이언스는 HIV, 바이러스성 간염, COVID-19 및 암과 같은 생명을 위협하는 질병에 대한 혁신적인 치료법에 집중하는 의약품 분야의 선도적인 회사로, 전 세계 35개국 이상에서 운영하고 있으며, 본사는 캘리포니아주 포스터 시티에 있습니다.
Gilead Sciences (Nasdaq: GILD) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le mercredi 6 novembre 2024, après la clôture du marché. La direction de l'entreprise animera un webcast à 16h30, heure de l'Est, pour discuter des résultats et fournir une mise à jour sur les affaires.
Un webcast en direct sera disponible dans la section Relations avec les investisseurs de www.gilead.com et sera archivé pendant un an. Gilead Sciences est une entreprise biopharmaceutique connue pour ses percées en médecine, en se concentrant sur des traitements innovants pour des maladies potentiellement mortelles telles que le VIH, l'hépatite virale, le COVID-19 et le cancer. L'entreprise opère dans plus de 35 pays à travers le monde, son siège étant situé à Foster City, Californie.
Gilead Sciences (Nasdaq: GILD) hat bekannt gegeben, dass es die Finanzergebnisse für das dritte Quartal 2024 am Mittwoch, den 6. November 2024, nach Börsenschluss veröffentlichen wird. Das Management des Unternehmens wird um 16:30 Uhr Eastern Time ein Webcast veranstalten, um die Ergebnisse zu diskutieren und ein Update zum Geschäft zu geben.
Ein Live-Webcast wird im Bereich Investor Relations auf www.gilead.com zur Verfügung stehen und dort ein Jahr lang archiviert. Gilead Sciences ist ein biopharmazeutisches Unternehmen, das für seine Durchbrüche in der Medizin bekannt ist, mit einem Fokus auf innovative Behandlungen für lebensbedrohliche Krankheiten wie HIV, Virushepatitis, COVID-19 und Krebs. Das Unternehmen ist in mehr als 35 Ländern weltweit tätig und hat seinen Sitz in Foster City, Kalifornien.
- None.
- None.
A live webcast will be available on the Investor Relations section of www.gilead.com and will be archived there for one year.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241009804907/en/
Jacquie Ross, CFA – Investors
investor_relations@gilead.com
Source: Gilead Sciences, Inc.
FAQ
When will Gilead Sciences (GILD) release its Q3 2024 financial results?
What time is Gilead Sciences' (GILD) Q3 2024 earnings webcast?
Where can I access Gilead Sciences' (GILD) Q3 2024 earnings webcast?
What are the main focus areas of Gilead Sciences (GILD)?
